Atrial fibrillation is associated with cardiac hypoxia

Cardiovascular Pathology

Volumn 19, Issue 2, 2010, Pages 102-111

  Gramley, Felix ^a   Lorenzen, Johann ^b   Jedamzik, Britta ^b   Gatter, Kevin ^c   Koellensperger, Eva ^d   Munzel, Thomas ^a   Pezzella, Francesco ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Arrhythmia; Atrial; Fibrosis; HIF1; Hypoxia

Indexed keywords

CARBONATE DEHYDRATASE IX; CD34 ANTIGEN; DYE; ENDOGLIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART RHYTHM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OXYGEN DIFFUSION; PRIORITY JOURNAL;

AGED; ANOXIA; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; CELL NUCLEUS; CORONARY VESSELS; CYTOPLASM; FEMALE; FIBROSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 75149145652     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2008.11.001     Document Type: Article

References (52)

1. Kannel W.B., Wolf P.A., Benjamin E.J., and Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 8A (1998) 2N-9N
2. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22 8 (1991) 983-988
3. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., and Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 10 (1998) 946-952
4. Shinagawa K., Shi Y.F., Tardif J.C., Leung T.K., and Nattel S. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 105 22 (2002) 2672-2678
5. Li D., Fareh S., Leung T.K., and Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100 1 (1999) 87-95
6. Sinno H., Derakhchan K., Libersan D., Merhi Y., Leung T.K., and Nattel S. Atrial ischemia promotes atrial fibrillation in dogs. Circulation 107 14 (2003) 1930-1936
7. De Boer R.A., Pinto Y.M., and Van Veldhuisen D.J. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation 10 2 (2003) 113-126
8. Thijssen V.L., van der Velden H.M., van Ankeren E.P., Ausma J., Allessie M.A., Borgers M., van Eys G.J., and Jongsma H.J. Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovasc Res 54 2 (2002) 427-437
9. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 6 (2003) 669-676
10. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2 1 (2002) 38-47
11. Duff S.E., Li C., Garland J.M., and Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17 9 (2003) 984-992
12. Sanfilippo A.J., Abascal V.M., Sheehan M., Oertel L.B., Harrigan P., Hughes R.A., and Weyman A.E. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 82 3 (1990) 792-797
13. Jamall I.S., Finelli V.N., and Que Hee S.S. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 112 1 (1981) 70-75
14. Neuman R.E., and Logan M.A. The determination of collagen and elastin in tissues. J Biol Chem 186 2 (1950) 549-556
15. Oken D.E., and Boucek R.J. Quantitation of collagen in human myocardium. Circ Res 5 4 (1957) 357-361
16. Stewart M., Talks K., Leek R., Turley H., Pezzella F., Harris A., and Gatter K. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology 40 3 (2002) 253-260
17. Fox S.B., Westwood M., Moghaddam A., Comley M., Turley H., Whitehouse R.M., Bicknell R., Gatter K.C., and Harris A.L. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 73 3 (1996) 275-280
18. Stewart M., Turley H., Cook N., Pezzella F., Pillai G., Ogilvie D., Cartlidge S., Paterson D., Copley C., Kendrew J., Barnes C., Harris A.L., and Gatter K.C. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study. Histopathology 43 1 (2003) 33-39
19. Talks K.L., Turley H., Gatter K.C., Maxwell P.H., Pugh C.W., Ratcliffe P.J., and Harris A.L. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157 2 (2000) 411-421
20. Gramley F., Lorenzen J., Plisiene J., Rakauskas M., Benetis R., Schmid M., Autschbach R., Knackstedt C., Schimpf T., Mischke K., Gressner A., Hanrath P., Kelm M., and Schauerte P. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation. J Cardiovasc Electrophysiol 18 10 (2007) 1076-1082
21. Wong A.K., Marais H.J., Jutzy K., Capestany G.A., and Marais G.E. Isolated atrial infarction in a patient with single vessel disease of the sinus node artery. Chest 100 1 (1991) 255-256
22. Lammers W.J., Kirchhof C., Bonke F.I., and Allessie M.A. Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol 262 1 Pt 2 (1992) H47-H55
23. Bunc M., Starc R., Podbregar M., and Brucan A. Conversion of atrial fibrillation into a sinus rhythm by coronary angioplasty in a patient with acute myocardial infarction. Eur J Emerg Med 8 2 (2001) 141-145
24. Kochiadakis G.E., Skalidis E.I., Kalebubas M.D., Igoumenidis N.E., Chrysostomakis S.I., Kanoupakis E.M., Simantirakis E.N., and Vardas P.E. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. Eur Heart J 23 9 (2002) 734-741
25. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., and Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 2 (2001) 174-180
26. Vester E.G. Myocardial ischemia and ventricular arrhythmia. Z Kardiol 87 Suppl 2 (1998) 49-60
27. Nattel S. Atrial electrophysiology and mechanisms of atrial fibrillation. J Cardiovasc Pharmacol Ther 8 Suppl 1 (2003) S5-S11
28. Wykoff C.C., Beasley N.J., Watson P.H., Turner K.J., Pastorek J., Sibtain A., Wilson G.D., Turley H., Talks K.L., Maxwell P.H., Pugh C.W., Ratcliffe P.J., and Harris A.L. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60 24 (2000) 7075-7083
29. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15 (1999) 551-578
30. Everett T.H., and Olgin J.E. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 4 3 Suppl (2007) S24-S27
31. Li X., Ma C., Dong J., Liu X., Long D., Tian Y., and Yu R. The fibrosis and atrial fibrillation: is the transforming growth factor-beta(1) a candidate etiology of atrial fibrillation. Med Hypotheses 70 2 (2008) 317-319
32. Seko Y., Nishimura H., Takahashi N., Ashida T., and Nagai R. Serum levels of vascular endothelial growth factor and transforming growth factor-beta1 in patients with atrial fibrillation undergoing defibrillation therapy. Jpn Heart J 41 1 (2000) 27-32
33. Schotten U., Neuberger H.R., and Allessie M.A. The role of atrial dilatation in the domestication of atrial fibrillation. Prog Biophys Mol Biol 82 1-3 (2003) 151-162
34. Inaba Y., Yuda S., Kobayashi N., Hashimoto A., Uno K., Nakata T., Tsuchihashi K., Miura T., Ura N., and Shimamoto K. Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr 18 7 (2005) 729-736
35. Kokubu N., Yuda S., Tsuchihashi K., Hashimoto A., Nakata T., Miura T., Ura N., Nagao K., Tsuzuki M., Wakabayashi C., and Shimamoto K. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of renin-angiotensin system inhibition on left atrial function. Hypertens Res 30 1 (2007) 13-21
36. Epstein N.D., and Davis J.S. Sensing stretch is fundamental. Cell 112 2 (2003) 147-150
37. Kim C.H., Cho Y.S., Chun Y.S., Park J.W., and Kim M.S. Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res 90 2 (2002) E25-E33
38. Li J., Hampton T., Morgan J.P., and Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest 100 1 (1997) 18-24
39. Lip G.Y. Does atrial fibrillation confer a hypercoagulable state?. Lancet 346 8986 (1995) 1313-1314
40. Chung N.A., Belgore F., Li-Saw-Hee F.L., Conway D.S., Blann A.D., and Lip G.Y. Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?. Stroke 33 9 (2002) 2187-2191
41. Roldan V., Marin F., Marco P., Martinez J.G., Calatayud R., and Sogorb F. Hypofibrinolysis in atrial fibrillation. Am Heart J 136 6 (1998) 956-960
42. Freestone B., Chong A., Lim H., Blann A., and Lip G. Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?. Ann Med 37 5 (2005) 365-372
43. Choudhury A., Freestone B., Patel J., and Lip G. Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?. Chest 32 6 (2007) 1913-1919
44. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., and Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 274 10 (1999) 6519-6525
45. Feng Y., Venema V.J., Venema R.C., Tsai N., and Caldwell R.B. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun 256 1 (1999) 192-197
46. Moroianu J., and Riordan J.F. Nuclear translocation of angiogenic proteins in endothelial cells: an essential step in angiogenesis. Biochemistry 33 42 (1994) 12535-12539
47. Zhang H.T., Scott P.A., Morbidelli L., Peak S., Moore J., Turley H., Harris A.L., Ziche M., and Bicknell R. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 83 1 (2000) 63-68
48. Jesmin S., Hattori Y., Togashi H., Ueno K., Yoshioka M., and Sakuma I. Age-related changes in cardiac expression of VEGF and its angiogenic receptor KDR in stroke-prone spontaneously hypertensive rats. Mol Cell Biochem 272 1-2 (2005) 63-73
49. Rutanen J., Rissanen T.T., Markkanen J.E., Gruchala M., Silvennoinen P., Kivela A., Hedman A., Hedman M., Heikura T., Orden M.R., Stacker S.A., Achen M.G., Hartikainen J., and Yla-Herttuala S. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109 8 (2004) 1029-1035
50. von Degenfeld G., Banfi A., Springer M.L., and Blau H.M. Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis. Br J Pharmacol 140 4 (2003) 620-626
51. Zhao L., and Eghbali-Webb M. Release of pro- and anti-angiogenic factors by human cardiac fibroblasts: effects on DNA synthesis and protection under hypoxia in human endothelial cells. Biochim Biophys Acta 1538 2-3 (2001) 273-282
52. Liu W., Ahmad S.A., Reinmuth N., Shaheen R.M., Jung Y.D., Fan F., and Ellis L.M. Endothelial cell survival and apoptosis in the tumor vasculature. Apoptosis 5 4 (2000) 323-328